Dr. Julie Rosenthal, MD

Dr. Rosenthal practices at Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic.

Dr. Rosenthal's NPI, 1326282302, was assigned on April 22, 2009. Dr. Rosenthal graduated from Drexel University College Of Medicine in 2009. Dr. Rosenthal holds Arizona license 52574.

Dr. Rosenthal's primary practice is Mayo Clinic Hospital - Phoenix, at 5777 East Mayo Boulevard, Phoenix, AZ 85054 in Maricopa County. The practice phone is (480) 342-4201.

Dr. Rosenthal's primary practice is Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic. The medical group on file is Mayo Clinic Arizona.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosenthal practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rosenthal's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Rosenthal is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Rosenthal's licenses on file in 2 states: Arizona and Ohio.

Dmand AI lists cardiomyopathy, congestive heart failure and heart failure among the conditions Dr. Rosenthal treats.

CMS data shows 997 Medicare services from Dr. Rosenthal across 7 procedure codes in 2024, for 859 Medicare patients. Medicare paid $42,578 for them.

CMS counts 859 Medicare patients who saw Dr. Rosenthal in 2024. The largest group is 75 to 84, with 361 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rosenthal's median patient age at 71, with 32% women.

In 2024, Dr. Rosenthal wrote 2,710 Medicare Part D claims for 316 patients. 61% of them were for generic drugs. CMS names the drug for 2,493 of them, across 44 drugs with 11 or more claims each, at $12,539,987 in total drug cost. In 2023, CMS named 1,751 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Rosenthal for performance year 2024, reported as part of a group. Dr. Rosenthal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rosenthal as offering telehealth.

Dmand AI links 28 papers to Dr. Rosenthal, published from 2013 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Heart Failure, Heart Transplantation and Cardiomyopathies. Dr. Rosenthal has published most often in JACC CardioOncol. Dr. Rosenthal's most frequent co-authors are Reza Arsanjani, MD, Chadi Ayoub, FACC, MD, PhD and Martha Grogan, MD.

CMS Open Payments shows 41 general payments to Dr. Rosenthal from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Novo Nordisk AS paid the most, $15,317.

Dr. Rosenthal graduated from Drexel University College Of Medicine in 2009. Dr. Rosenthal is a member of ACC, HFSA and ISHLT.

Dr. Rosenthal is in network with 4 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.